Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-24-265556
Filing Date
2024-11-26
Accepted
2024-11-26 06:03:55
Documents
2
Group Members
FRED A. MIDDLETONSANDERLING VENTURE PARTNERS VI CO-INVESTMENT FUND, L.P.SANDERLING VENTURES MANAGEMENT VISANDERLING VENTURES MANAGEMENT VIISANDERLING VENTURES VII (CANADA), L.P.SANDERLING VENTURES VII ANNEX FUND, L.P.SANDERLING VENTURES VII, L.P.SANDERLIN

Document Format Files

Seq Description Document Type Size
1 SC 13D d865711dsc13d.htm SC 13D 238374
2 EX-99.A d865711dex99a.htm EX-99.A 17913
  Complete submission text file 0001193125-24-265556.txt   258611
Mailing Address 1300 S EL CAMINO REAL SUITE 203 SAN MATEO CA 94402
Business Address 1300 S EL CAMINO REAL SUITE 203 SAN MATEO CA 94402 650-401-2000
Sanderling Venture Partners VI LP (Filed by) CIK: 0001306717 (see all company filings)

EIN.: 201044833
Type: SC 13D

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 307 LA JOLLA CA 92037 858-952-5500
CalciMedica, Inc. (Subject) CIK: 0001534133 (see all company filings)

EIN.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91725 | Film No.: 241498000
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)